Emerging Biomarkers for Monitoring Bladder Cancer Progression

The presentation explores emerging inflammatory biomarkers in non-muscle-invasive bladder cancer (NMIBC) progression, focusing on dynamic monitoring post-TURBT using markers like NLR, PLR, and coagulation indicators. A single-centre pilot study evaluates biomarker changes through longitudinal analyses, aiming to overcome limitations of static measures while addressing recurrence and surveillance burdens. Preliminary findings highlight NLR reductions post-TURBT and potential integration into...